Both in Pharmaceuticals
Marker Therapeutics vs Bolt Biotherapeutics
Over the past year MRKR returned −6.1% and BOLT returned +11.8%; their daily moves had a correlation of 0.10.
MRKR −6.1% BOLT +11.8%Growth of $1, one year, split-adjusted
| Metric | MRKR | BOLT |
|---|---|---|
| Price | $0.9011 | $6.24 |
| Market cap | $15.0M | $14.7M |
| Today | −8.05% | −5.31% |
| 1 month | −14.2% | +80.9% |
| 6 months | −42.2% | +23.3% |
| Year to date | −39.5% | +14.1% |
| 1 year | −8.7% | +8.9% |
| Revenue growth (YoY) | — | −99.7% |
| Gross margin | — | 100.0% |
| Net margin | — | −154400.0% |
| P/E (TTM) | — | — |
| Price / sales | 6.4× | 3.1× |
| Net cash | $11.3M | $17.6M |
| Dividend yield | — | — |
| Volatility (60d) | 83.9% | 112.1% |
| Short % of float | 0.8% | 1.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).